Total Payments
$16,180
2024 Payments
$1,859
Companies
63
Transactions
956
Medicare Patients
2,135
Medicare Billing
$340,236
Payment Breakdown by Category
Food & Beverage$14,286 (88.3%)
Consulting$1,605 (9.9%)
Education$288.34 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,286 | 937 | 88.3% |
| Consulting Fee | $1,605 | 3 | 9.9% |
| Education | $288.34 | 16 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,768 | 113 | $0 (2024) |
| Varian Medical Systems, Inc. | $1,605 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $1,270 | 79 | $0 (2024) |
| PFIZER INC. | $1,067 | 83 | $0 (2024) |
| Genentech USA, Inc. | $849.86 | 66 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $836.04 | 69 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $769.08 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $740.72 | 44 | $0 (2024) |
| Amgen Inc. | $649.98 | 45 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $470.97 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,859 | 105 | Novartis Pharmaceuticals Corporation ($302.96) |
| 2023 | $1,925 | 111 | Novartis Pharmaceuticals Corporation ($248.98) |
| 2022 | $2,709 | 152 | Novartis Pharmaceuticals Corporation ($226.80) |
| 2021 | $2,495 | 119 | Varian Medical Systems, Inc. ($625.00) |
| 2020 | $980.91 | 31 | Varian Medical Systems, Inc. ($500.00) |
| 2019 | $2,635 | 162 | Varian Medical Systems, Inc. ($480.00) |
| 2018 | $1,919 | 145 | Novartis Pharmaceuticals Corporation ($306.38) |
| 2017 | $1,657 | 131 | Novartis Pharmaceuticals Corporation ($291.02) |
All Payment Transactions
956 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Monoclonal Antibody | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: BioOncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TALVEY | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Oncology | ||||||
| 11/13/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Oncology | ||||||
| 11/05/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/31/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.87 | General |
| 10/15/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.47 | General |
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 428 | 1,130 | $174,546 | $76,645 |
| 2022 | 4 | 527 | 1,167 | $182,455 | $81,295 |
| 2021 | 4 | 565 | 1,394 | $205,823 | $100,867 |
| 2020 | 5 | 615 | 1,371 | $176,871 | $81,428 |
Total Patients
2,135
Total Services
5,062
Medicare Billing
$340,236
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 795 | $123,473 | $54,262 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 97 | $21,049 | $9,812 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 212 | $23,108 | $9,034 | 39.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $6,916 | $3,537 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 801 | $124,127 | $54,821 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 98 | $21,266 | $10,578 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 218 | $23,762 | $9,517 | 40.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 50 | 50 | $13,300 | $6,379 | 48.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 261 | 1,023 | $151,173 | $74,154 | 49.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 190 | 243 | $25,047 | $10,917 | 43.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 57 | 71 | $14,777 | $8,126 | 55.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 57 | 57 | $14,826 | $7,669 | 51.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 231 | 870 | $110,557 | $50,438 | 45.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 227 | 307 | $26,095 | $10,498 | 40.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 70 | 102 | $17,544 | $8,555 | 48.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 65 | 65 | $15,925 | $7,650 | 48.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 27 | $6,750 | $4,288 | 63.5% |
About Dr. Jonathan Storey, MD
Dr. Jonathan Storey, MD is a Hematology & Oncology healthcare provider based in Boaz, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659568012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Storey, MD has received a total of $16,180 in payments from pharmaceutical and medical device companies, with $1,859 received in 2024. These payments were reported across 956 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($14,286).
As a Medicare-enrolled provider, Storey has provided services to 2,135 Medicare beneficiaries, totaling 5,062 services with total Medicare billing of $340,236. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Boaz, AL
- Active Since 10/01/2007
- Last Updated 10/03/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659568012
Products in Payments
- KEYTRUDA (Biological) $1,193
- OPDIVO (Biological) $662.62
- ARIA Radiation Therapy Management Software (Device) $625.00
- KISQALI (Drug) $556.74
- OTHER (Device) $500.00
- IBRANCE (Drug) $330.64
- DARZALEX (Biological) $316.08
- IMBRUVICA (Drug) $307.86
- PROMACTA (Drug) $301.34
- XTANDI (Drug) $250.72
- Lenvima (Drug) $241.61
- ADCETRIS (Biological) $241.57
- VENCLEXTA (Drug) $237.50
- PADCEV (Biological) $215.16
- ICLUSIG (Drug) $215.02
- JAKAFI (Drug) $197.67
- ELIQUIS (Drug) $190.69
- NINLARO (Drug) $183.59
- LIBTAYO (Biological) $180.33
- Trodelvy (Drug) $173.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.